Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats
- PMID:12872290
- DOI: 10.1002/syn.10242
Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats
Abstract
Bupropion is an atypical antidepressant drug that is the only nonnicotine-based prescription medicine approved for smoking cessation by the Food and Drug Administration. The aim of the present experiments was to investigate the effects of bupropion (5-40 mg/kg) on the reinforcing properties of nicotine and food in rats. The effects of bupropion were studied under two schedules of reinforcement: a fixed ratio 5 time-out 20-sec (FR5 TO20 s) and a progressive ratio (PR). Rats were trained to respond for nicotine (0.01 or 0.03 mg/kg/infusion, free base) or food under the FR5 TO20 s schedule. Pretreatment with the highest dose of bupropion (40 mg/kg) resulted in a significant reduction (approximately 50%) of nicotine intake in rats self-administering 0.03 mg/kg/infusion of nicotine. The same dose of bupropion also decreased (approximately 40%) the self-administration of 0.01 mg/kg/infusion of nicotine, but this effect did not reach statistical significance. Pretreatment with bupropion slightly (approximately 15%) reduced responding for food under the FR5 TO20 s schedule. Finally, pretreatment with bupropion did not affect the self-administration of nicotine (0.03 mg/kg/infusion) under a PR schedule, but dose-dependently increased responding for food under the same PR schedule. These findings indicate that a high dose of bupropion decreases the reinforcing properties of nicotine as measured under an FR schedule, while having no apparent effects on breaking points for nicotine under a PR schedule that reflects both the reinforcing properties and the motivation to obtain nicotine.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
- Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.Vann RE, Rosecrans JA, James JR, Philibin SD, Robinson SE.Vann RE, et al.Brain Res. 2006 Oct 30;1117(1):18-24. doi: 10.1016/j.brainres.2006.07.110. Epub 2006 Sep 1.Brain Res. 2006.PMID:16949560
- Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell.Paterson NE, Balfour DJ, Markou A.Paterson NE, et al.Eur J Neurosci. 2007 May;25(10):3099-108. doi: 10.1111/j.1460-9568.2007.05546.x.Eur J Neurosci. 2007.PMID:17561823
- Rate-dependent effects of bupropion on nicotine self-administration and food-maintained responding in rats.Stairs DJ, Dworkin SI.Stairs DJ, et al.Pharmacol Biochem Behav. 2008 Oct;90(4):701-11. doi: 10.1016/j.pbb.2008.05.014.Pharmacol Biochem Behav. 2008.PMID:18602678
- The neurobiology of tobacco dependence: a commentary.Balfour DJ.Balfour DJ.Respiration. 2002;69(1):7-11. doi: 10.1159/000049362.Respiration. 2002.PMID:11844955Review.
- Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.Dwoskin LP, Rauhut AS, King-Pospisil KA, Bardo MT.Dwoskin LP, et al.CNS Drug Rev. 2006 Fall-Winter;12(3-4):178-207. doi: 10.1111/j.1527-3458.2006.00178.x.CNS Drug Rev. 2006.PMID:17227286Free PMC article.Review.
Cited by
- Metabotropic glutamate 5 receptor (mGluR5) antagonists decrease nicotine seeking, but do not affect the reinforcement enhancing effects of nicotine.Palmatier MI, Liu X, Donny EC, Caggiula AR, Sved AF.Palmatier MI, et al.Neuropsychopharmacology. 2008 Aug;33(9):2139-47. doi: 10.1038/sj.npp.1301623. Epub 2007 Nov 28.Neuropsychopharmacology. 2008.PMID:18046312Free PMC article.
- Bupropion attenuates nicotine abstinence syndrome in the rat.Malin DH, Lake JR, Smith TD, Khambati HN, Meyers-Paal RL, Montellano AL, Jennings RE, Erwin DS, Presley SE, Perales BA.Malin DH, et al.Psychopharmacology (Berl). 2006 Mar;184(3-4):494-503. doi: 10.1007/s00213-005-0135-z. Epub 2005 Sep 15.Psychopharmacology (Berl). 2006.PMID:16163521
- The D1/D2-like receptor antagonist flupentixol and the D2-like receptor antagonist L-741626 decrease operant responding for nicotine and food and locomotor activity in male and female rats.Chellian R, Behnood-Rod A, Wilson R, Lin K, Wing-Yan King G, Bruijnzeel AW.Chellian R, et al.J Psychopharmacol. 2023 Feb;37(2):216-228. doi: 10.1177/02698811221147141. Epub 2023 Jan 21.J Psychopharmacol. 2023.PMID:36680471Free PMC article.
- Shifting Frontiers in Basic Research on Nicotine and Tobacco Products.Bruijnzeel AW.Bruijnzeel AW.Nicotine Tob Res. 2020 Feb 6;22(2):145-146. doi: 10.1093/ntr/ntz190.Nicotine Tob Res. 2020.PMID:31566234Free PMC article.No abstract available.
- Rewarding Effects of Nicotine in Adolescent and Adult Male and Female Rats as Measured Using Intracranial Self-stimulation.Xue S, Behnood-Rod A, Wilson R, Wilks I, Tan S, Bruijnzeel AW.Xue S, et al.Nicotine Tob Res. 2020 Feb 6;22(2):172-179. doi: 10.1093/ntr/nty249.Nicotine Tob Res. 2020.PMID:30452710Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials